Bioserenity
Bioserenity is an epilepsy Diagnosis founded in 2014 by Pierre Frouin.
6
Funding Rounds
$189.7m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Pi**** Fr**** | - | - |
Funding
Funding series
Funding Series Analysis
The company Bioserenity has raised a total of $189.73m in funding over 6 rounds.
Key Insights:
- BioSerenity November 2023 Series B Funding Round: $26m
- BioSerenity June 2019 Series B Funding Round: $71m
- BioSerenity Series B round, June 2019: $73.4m
- BioSerenity September 2017 Series A Funding Round: $16m
- BioSerenity November 2015 Seed Funding Round: $3.2m
- BioSerenity September 2014 Pre-Seed Funding Round: $130k
BioSerenity November 2023 Series B Funding Round
$26m
BioSerenity June 2019 Series B Funding Round
$71m
BioSerenity Series B round, June 2019
$73.4m
BioSerenity September 2017 Series A Funding Round
$16m
BioSerenity November 2015 Seed Funding Round
$3.2m
BioSerenity September 2014 Pre-Seed Funding Round
$130k
Industries
Bioserenity is active in the following industries:
- Internet of things (IoT)
- Healthcare
- Artificial Intelligence (AI)
- Biomedical engineering
- Diagnosis
- Neuroscience
- Neurotechnology
- Engineering
- Technology
- Health technology